首页> 外国专利> ELIMINATION PROBE-BASED METHOD FOR DETECTING NUMERICAL CHROMOSOMAL ABNORMALITIES, AND NUCLEIC ACID COMPOSITION FOR DETECTING NUMERICAL CHROMOSOMAL ABNORMALITIES

ELIMINATION PROBE-BASED METHOD FOR DETECTING NUMERICAL CHROMOSOMAL ABNORMALITIES, AND NUCLEIC ACID COMPOSITION FOR DETECTING NUMERICAL CHROMOSOMAL ABNORMALITIES

机译:用于检测数值染色体异常的基于消除探针的方法,以及用于检测数值染色体异常的核酸组合物

摘要

The present invention relates to a method for analyzing the presence or absence of aneuploidy of a target chromosome with high sensitivity, and a composition for detecting chromosomal aneuploidy, and more particularly to a method of identifying chromosomal aneuploidy by amplifying a control nucleotide sequence, located on a chromosome not associated with chromosomal aneuploidy, and a target nucleotide sequence located on a chromosome associated with chromosomal aneuploidy, by using the same primer, and then hybridizing the amplification products with an assay probe that differs by one or two nucleotides from the control nucleotide sequence and with an elimination probe that comprises part or all of a sequence of the assay probe, which hybridizes with the target nucleotide sequence or the control nucleotide sequence, the elimination probe having a higher binding affinity for the amplification products than the assay probe, and analyzing melting curves of the hybridization products. The method for detecting chromosomal aneuploidy according to the present invention may analyze the ratio of the target nucleotide sequence to the control nucleotide sequence at high resolution by eliminating equal amounts (certain proportions) of the target nucleotide sequence and the control nucleotide sequence from the analysis using the elimination sequence. This method is useful because numerical abnormalities (aneuploidy) in chromosomes (e.g., fetal chromosomes in maternal blood, and circulating tumor DNA in cancer patients) present at low rates can be detected quickly with high sensitivity by the use of this method.
机译:本发明涉及一种高灵敏度分析目标染色体是否存在非整倍体的方法,以及一种检测染色体非整倍体的组合物,更具体地说,本发明涉及一种通过扩增位于与染色体非整倍体无关的染色体上的控制核苷酸序列来识别染色体非整倍体的方法,以及位于与染色体非整倍体相关的染色体上的靶核苷酸序列,方法是使用相同的引物,然后将扩增产物与与与对照核苷酸序列相差一个或两个核苷酸的分析探针以及包含部分或全部分析探针序列的消除探针杂交,与靶核苷酸序列或对照核苷酸序列杂交,消除探针对扩增产物的结合亲和力高于分析探针,并分析杂交产物的熔化曲线。根据本发明的检测染色体非整倍体的方法可以通过从使用消除序列的分析中消除等量(一定比例)的目标核苷酸序列和控制核苷酸序列,以高分辨率分析目标核苷酸序列与控制核苷酸序列的比率。这种方法很有用,因为使用这种方法可以快速、高灵敏度地检测出低比率染色体(如母体血液中的胎儿染色体和癌症患者中的循环肿瘤DNA)中的数值异常(非整倍体)。

著录项

  • 公开/公告号US2022127665A1

    专利类型

  • 公开/公告日2022-04-28

    原文格式PDF

  • 申请/专利权人 SEASUN BIOMATERIALS;

    申请/专利号US201917265102

  • 申请日2019-07-23

  • 分类号C12Q1/6832;C12Q1/6825;C12Q1/6818;C12Q1/686;C12Q1/6883;

  • 国家 US

  • 入库时间 2022-08-25 00:46:23

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号